Vice directors of the Liangjiang government administration, Hao Ming and Li Chengyun, have investigated the innovative development progress of hi-tech enterprises in Liangjiang's Shuitu Hi-tech Industrial Park on Feb 11.

Hao and Li visited local hi-tech enterprises in the park, including the Chongqing Daxin Pharmaceutical Corporation and Chongqing Huashu Robot Enterprise. A symposium was held was held to better understand the innovation development of the local hi-tech enterprises in the area.

The Chongqing Daxin Pharmaceutical Corporation's first stage project occupies a total area of 60 hectares, with an annual output value of 600 million yuan ($95.94 million). It has developed innovation in different areas; including microbe fermentation technology, green organic synthesis technology and production facilities. In addition, the company has obtained patents in different fields.

In the recent years, Chongqing's pharmaceutical industry has been developing rapidly. Three pharmaceutical industry development clusters have been constructed in Chongqing, including one in the Liangjiang New Area. According to statistics from Liangjiang New Area, the pharmaceutical production area in Liajing is expected to reach 7.3-square-kilometers.

According the 2015 annual plan of the Liangjiang New Area, about 100 pharmaceutical projects are expected to enter the area and about 1,000 innovative talent will be hired.

Hao and Li visited the Science and Technology Support Center in the Shuitu Industrial Park. They also directed and guided the work from four aspects: innovation reform, capital turnover, market analysis and transportation.

Edited by Jacob Hooson